Integrative MeRIP-Seq and RNA-Seq Analyses Reveal Innate Immune and Infection-Related Transcriptomic Changes upon

Qian Tang1,2, Yong Hu2, Lin Zhu2

  • 1School of Life Sciences and Medical Engineering, Anhui University, Hefei 230601, China.

Genes
|July 28, 2026
PubMed

Insights

Methyltransferase-like 3 (METTL3) regulates mRNA methylation, impacting gene expression. Depleting METTL3 altered thousands of genes, revealing its role in innate immunity and potential as an anti-infection target.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Immunology

Background:

  • Methyltransferase-like 3 (METTL3) is a key enzyme catalyzing N6-methyladenosine (m6A) mRNA modifications.
  • METTL3 influences RNA splicing, stability, and distribution, playing a crucial role in gene regulation.
  • The global impact of METTL3 on mRNA methylation patterns remains incompletely understood.

Purpose of the Study:

  • To elucidate the global landscape of mRNA methylation alterations driven by METTL3.
  • To identify specific genes and pathways regulated by METTL3-mediated m6A modification.
  • To explore the role of METTL3 in innate immune responses against pathogens.

Main Methods:

  • Constructed a HEK293T cell line with METTL3 depletion.
  • Performed RNA sequencing (RNA-seq) and methylated RNA Immunoprecipitation Sequencing (MeRIP-seq).
  • Utilized quantitative Reverse Transcription PCR (qRT-PCR) for gene expression validation.

Main Results:

  • Characterized the mRNA methylation alteration landscape upon METTL3 depletion.
  • Identified 5763 hypomethylated and 269 hypermethylated genes after METTL3 silencing.
  • Discovered METTL3-regulated innate immune genes (e.g., MYD88, RIG-1, CYLD, IRF9) enriched in pathogen infection and immune response pathways.

Conclusions:

  • METTL3 significantly impacts the global mRNA methylation profile.
  • METTL3-regulated genes are involved in crucial innate immune pathways, including responses to Shigellosis, Yersinia, and HIV-1.
  • METTL3 and its regulated genes represent potential therapeutic targets for combating infections.